Quick Answer
BioCardia, Inc. reported Net Income Loss of -$8.23 million for the year ending 2025.
- BioCardia, Inc. showed a decrease of -3.5% in Net Income Loss from 2024 to 2025.
- This data is from BioCardia, Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $64.0 thousand | Q2 2014: $66.0 thousand | Q3 2014: $43.0 thousand | Q1 2015: $76.0 thousand | Q2 2015: $73.0 thousand | Q3 2015: $83.0 thousand | Q1 2016: -$1.50 million | Q2 2016: -$1.98 million | Q3 2016: -$3.25 million | Q1 2017: -$2.88 million | Q2 2017: -$2.95 million | Q3 2017: -$3.00 million | Q1 2018: -$3.58 million | Q2 2018: -$3.22 million | Q3 2018: -$3.54 million | Q1 2019: -$3.67 million | Q2 2019: -$3.75 million | Q3 2019: -$3.79 million | Q1 2020: -$4.59 million | Q2 2020: -$3.57 million | Q3 2020: -$3.85 million | Q1 2021: -$2.97 million | Q2 2021: -$3.49 million | Q3 2021: -$2.71 million | Q1 2022: -$3.33 million | Q2 2022: -$2.50 million | Q3 2022: -$3.06 million | Q1 2023: -$3.50 million | Q2 2023: -$3.42 million | Q3 2023: -$2.57 million | Q1 2024: -$2.27 million | Q2 2024: -$1.65 million | Q3 2024: -$1.74 million | Q1 2025: -$2.71 million | Q2 2025: -$2.05 million | Q3 2025: -$1.48 million.
- Over the full 16 years of available data (2010 to 2025), BioCardia, Inc.'s Net Income Loss has grown by 28.5%.
- Historical annual values: Fiscal year 2025: -$8.23 million | Fiscal year 2024: -$7.95 million | Fiscal year 2023: -$11.57 million | Fiscal year 2022: -$11.91 million | Fiscal year 2021: -$12.62 million | Fiscal year 2020: -$15.00 million | Fiscal year 2019: -$14.71 million | Fiscal year 2018: -$13.99 million | Fiscal year 2017: -$12.31 million | Fiscal year 2016: -$10.31 million | Fiscal year 2015: -$6.70 million | Fiscal year 2014: $234.0 thousand | Fiscal year 2013: $19.0 thousand | Fiscal year 2012: $305.0 thousand | Fiscal year 2011: $9.66 million | Fiscal year 2010: -$11.51 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: